Precision Health Clinical Trials
Comparison of Biological Features Between pN0 Triple Negative Breast Tumours With Size < or = 10 mm (pT1a/b) Versus pT1c T2 < or = 30 mm
Condition: Triple Negative Breast Cancers Without Lymph-node Involvement and Intervention: Procedure: Blood samples of 10 mL
Sponsor: Institut Claudius Regaud
Recruiting
Sponsor: Institut Claudius Regaud
Recruiting
For more information, visit the Study URL.
Cerebellar Mutism Syndrome Study
Conditions: Infratentorial Neoplasms; Mutism
Intervention:
Sponsors: Rigshospitalet, Denmark; Odense University Hospital; Aarhus University Hospital; Aalborg University Hospital; Technical University of Denmark; Karolinska University Hospital; Skane University Hospital; University Hospital, Linkoeping; Uppsala University Hospital; Sahlgrenska University Hospital, Sweden; University Hospital, Umeå; Oslo University Hospital; Trondheim University Hospital; Haukeland University Hospital; University Hospital of North Norway; Helsinki University Central Hospital; Tampere University Hospital; Kuopio University Hospital; Turku University Hospital; Oulu University Hospital; Radboud University Medical Center; Liverpool University Hospitals NHS Foundation Trust; Great Ormond Street Hospital for Children NHS Foundation Trust; Nottingham University Hospitals NHS Trust; University Hospital Birmingham; University Hospitals Bristol and Weston NHS Foundation Trust; Royal Infirmary of Edinburgh; South Glasgow University Hospitals NHS Trust; University Hospital Tuebingen; Medical University of Vienna; Ospedale Pediatrico Bambin Gesù
Recruiting
Intervention:
Sponsors: Rigshospitalet, Denmark; Odense University Hospital; Aarhus University Hospital; Aalborg University Hospital; Technical University of Denmark; Karolinska University Hospital; Skane University Hospital; University Hospital, Linkoeping; Uppsala University Hospital; Sahlgrenska University Hospital, Sweden; University Hospital, Umeå; Oslo University Hospital; Trondheim University Hospital; Haukeland University Hospital; University Hospital of North Norway; Helsinki University Central Hospital; Tampere University Hospital; Kuopio University Hospital; Turku University Hospital; Oulu University Hospital; Radboud University Medical Center; Liverpool University Hospitals NHS Foundation Trust; Great Ormond Street Hospital for Children NHS Foundation Trust; Nottingham University Hospitals NHS Trust; University Hospital Birmingham; University Hospitals Bristol and Weston NHS Foundation Trust; Royal Infirmary of Edinburgh; South Glasgow University Hospitals NHS Trust; University Hospital Tuebingen; Medical University of Vienna; Ospedale Pediatrico Bambin Gesù
Recruiting
For more information, visit the Study URL.
Ponatinib for Patients Whose Advanced Solid Tumor Cancer Has Activating Mutations Involving the Following Genes: FGFR1, FGFR2, FGFR3, FGFR4, RET, KIT.
Condition: Malignant Neoplasm
Interventions: Drug: ponatinib hydrochloride; Other: laboratory biomarker analysis
Sponsor: Sameek Roychowdhury
Recruiting
Interventions: Drug: ponatinib hydrochloride; Other: laboratory biomarker analysis
Sponsor: Sameek Roychowdhury
Recruiting
For more information, visit the Study URL.
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases
Condition: Retinitis Pigmentosa
Intervention: Genetic: Genetic testing
Sponsors: Hillel Yaffe Medical Center; Technion, Israel Institute of Technology
Not yet recruiting
Intervention: Genetic: Genetic testing
Sponsors: Hillel Yaffe Medical Center; Technion, Israel Institute of Technology
Not yet recruiting
For more information, visit the Study URL.
Using Microbial Genomics to Elucidate the Source of Central-line Associated Bloodstream Infections
Conditions: Laboratory-confirmed Bloodstream Infection; Central Line-associated Bloodstream Infections; Mucosal Barrier Injury
Intervention:
Sponsor: Boston Children's Hospital
Recruiting
Intervention:
Sponsor: Boston Children's Hospital
Recruiting
For more information, visit the Study URL.
Comprehensive Genomic Analysis in Tissue and Blood Samples From Young Patients With Lung Cancer
Conditions: Non-small Cell Lung Cancer; Small Cell Lung Cancer
Interventions: Other: cytology specimen collection procedure; Other: laboratory biomarker analysis
Sponsors: University of Southern California; Foundation Medicine; Addario Lung Cancer Medical Institute; National Cancer Institute (NCI)
Recruiting
Interventions: Other: cytology specimen collection procedure; Other: laboratory biomarker analysis
Sponsors: University of Southern California; Foundation Medicine; Addario Lung Cancer Medical Institute; National Cancer Institute (NCI)
Recruiting
For more information, visit the Study URL.
SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Interventions: Drug: AZD2014; Drug: AZD4547; Drug: AZD5363; Drug: AZD8931; Drug: Selumetinib; Drug: Vandetanib; Drug: Bicalutamide; Drug: Olaparib; Drug: Anthracyclines; Drug: Taxanes; Drug: cyclophosphamide; Drug: DNA intercalators; Drug: Methotrexate; Drug: vinca alkaloids; Drug: Platinum based chemotherapies; Drug: Bevacizumab; Drug: Mitomycin C; Drug: Eribulin; Drug: MEDI4736
Sponsors: UNICANCER; Fondation ARC; AstraZeneca
Recruiting
Interventions: Drug: AZD2014; Drug: AZD4547; Drug: AZD5363; Drug: AZD8931; Drug: Selumetinib; Drug: Vandetanib; Drug: Bicalutamide; Drug: Olaparib; Drug: Anthracyclines; Drug: Taxanes; Drug: cyclophosphamide; Drug: DNA intercalators; Drug: Methotrexate; Drug: vinca alkaloids; Drug: Platinum based chemotherapies; Drug: Bevacizumab; Drug: Mitomycin C; Drug: Eribulin; Drug: MEDI4736
Sponsors: UNICANCER; Fondation ARC; AstraZeneca
Recruiting
For more information, visit the Study URL.
Detection of Tumor DNA in Blood Samples From Cancer Patients
Conditions: Cancer; Tumors
Intervention: Diagnostic Test: Blood test
Sponsor: Lexent Bio, Inc.
Recruiting
Intervention: Diagnostic Test: Blood test
Sponsor: Lexent Bio, Inc.
Recruiting
For more information, visit the Study URL.
Genomic Response Analysis of Heart Failure Therapy in African Americans
Condition: Heart Failure
Intervention: Drug: FDC I/H
Sponsor: University of Pittsburgh
Recruiting
Intervention: Drug: FDC I/H
Sponsor: University of Pittsburgh
Recruiting
For more information, visit the Study URL.
Genes Involved in Lipid Disorders
Condition: Lipid Disorders
Intervention:
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting
Intervention:
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting
For more information, visit the Study URL.